> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Info Collection on Compounding Bulk Drug Substances
- URL: https://www.fdaweb.com/info-collection-on-compounding-bulk-drug-substances/
- Published: 2018-09-17T12:00:00.000Z
- Updated: 2026-09-15T00:32:17.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5142364

*Federal Register* notice: FDA is seeking comments on a proposed information collection entitled “Clinical Use of Bulk Drug Substances Nominated for Use in Compounding by Outsourcing Facilities” (OMB Control Number 0910-NEW). The information collection would support agency-sponsored research. To evaluate nominated substances, FDA has proposed a research study on their use in clinical practice by examining their current and historical use in compounding. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-09-17/pdf/2018-20092.pdf?ref=fdaweb.com).